GO
Loading...

Health Care Equipment and Supplies

More

  • Final Glance: Medical Devices companies Friday, 20 Mar 2015 | 8:00 PM ET

    Baxter International Inc. rose$. 20 or. 3 percent, to $68.18. Boston Scientific Corp. rose$. 03 or. 2 percent, to $17.84. Zimmer Holdings Inc. rose$. 20 or. 2 percent, to $118.76.

  • Midday Glance: Medical Devices companies Friday, 20 Mar 2015 | 1:25 PM ET

    Baxter International Inc. fell$. 03 or percent, to $67.95. Boston Scientific Corp. rose$. 10 or. 5 percent, to $17.91. Johnson& Johnson rose$. 67 or. 7 percent, to $102.36.

  • Early Glance: Medical Devices companies Friday, 20 Mar 2015 | 10:19 AM ET

    Baxter International Inc. rose$. 23 or. 3 percent, to $68.21. Boston Scientific Corp. rose$. 29 or 1.6 percent, to $18.10. St. Jude Medical Inc. rose$. 16 or. 2 percent, to $66.83.

  • Midday Glance: Medical Devices companies Thursday, 19 Mar 2015 | 2:00 PM ET

    Baxter International Inc. fell$. 62 or. 9 percent, to $67.94. Boston Scientific Corp. fell$. 16 or. 9 percent, to $17.60. Johnson& Johnson rose$. 18 or. 2 percent, to $101.64.

  • Early Glance: Medical Devices companies Thursday, 19 Mar 2015 | 10:22 AM ET

    Baxter International Inc. fell$. 38 or. 6 percent, to $68.17. Boston Scientific Corp. fell$. 03 or. 2 percent, to $17.73. St. Jude Medical Inc. rose$. 27 or. 4 percent, to $65.85.

  • Midday Glance: Medical Devices companies Wednesday, 18 Mar 2015 | 2:23 PM ET

    Baxter International Inc. fell$. 81 or 1.2 percent, to $67.66. Boston Scientific Corp. rose$. 04 or. 2 percent, to $17.44. Johnson& Johnson fell$. 42 or. 4 percent, to $99.47.

  • Early Glance: Medical Devices companies Wednesday, 18 Mar 2015 | 11:37 AM ET

    Baxter International Inc. fell$. 21 or. 3 percent, to $68.26. Boston Scientific Corp. rose$. 14 or. 8 percent, to $17.55. Johnson& Johnson fell$. 02 or percent, to $99.87.

  • March 16- A minimally invasive procedure that allows doctors to implant a new heart valve supplying blood to the body is safe for low-risk patients, according to a study presented at the American College of Cardiology meeting in San Diego. Samir Kapadia, a cardiologist at the Cleveland Clinic in Ohio. The results presented Sunday are of particular interest for...

  • The FDA action followed reports last month that hundreds of patients may have been exposed to pathogens, including antibiotic-resistant "superbugs," after flexible tubes called duodenoscopes were not properly disinfected between patients. The recommendations are based on draft proposals the FDA released for public comment in 2011 but never put into...

  • UPDATE 1-FDA says panel to discuss "superbug" spread Thursday, 12 Mar 2015 | 10:46 AM ET

    The gastroenterology and urology devices panel would meet on May 14-15, FDA said on Thursday. A top FDA official said earlier this month that manufacturers' tests of procedures to clean medical scopes linked with "superbug" outbreaks contained flaws that render their cleaning instructions unreliable. Olympus Corp, Fujifilm Holdings Corp and Pentax Medical...

  • In a letter released on Wednesday, the organization urged Health and Human Services Secretary Sylvia Burwell to withdraw the proposal, saying pharmaceutical companies could "sell more drugs by making them seem safer than FDA has judged them to be." The FDA said it would allow distribution of new information in medical journals showing that the severity or...

  • Got diabetes? There's an app for that Monday, 9 Mar 2015 | 6:34 PM ET

    CHICAGO, March 9- U.S. health researchers said on Monday they are targeting millions of smartphone users with Apple Inc's new software tool, hoping to collect an unprecedented amount of data on major diseases by tracking their behaviors via iPhone. Scientists from Stanford University School of Medicine and Weill Cornell Medical College are among the first to...

  • CHICAGO, March 9- Apple Inc on Monday released ResearchKit, an open-source software tool designed to give scientists a new way to gather information on patients by using their iPhones. They include Stanford University School of Medicine and Weill Cornell Medical College. "With hundreds of millions of iPhones in use around the world, we saw an opportunity for...

  • SEATTLE, March 5- A Washington state woman has filed a lawsuit against a hospital and a leading medical-device manufacturer claiming her husband died from a drug-resistant "superbug" he contracted from a contaminated medical scope, her lawyer said on Thursday. Theresa Bigler, of Woodway, is seeking unspecified monetary damages for the death of her husband...

  • The scopes were linked to the exposure of 179 patients to drug-resistant bacteria at UCLA's Ronald Reagan Medical Center in Los Angeles and may have contributed to two deaths. In early 2014, following a superbug outbreak at a hospital in Illinois, the FDA asked Fujifilm Holdings Corp, Olympus Corp and Pentax, which make the devices, to submit their test results...

  • *Cyberonics will have 54 pct of new group; Sorin 46 pct. MILAN, Feb 26- Italian medical device maker Sorin and its smaller U.S. peer Cyberonics Inc announced a merger on Thursday to create a global leader in cardiac surgery and neuromodulation with an equity value of $2.7 billion. Sorin's boss Andre-Michel Ballester will become chief executive and the board will be...

  • MILAN, Feb 26- United States- based medical device maker Cyberonics Inc has agreed to buy Sorin SpA in an all-stock deal that the Italian company said values it at about $1.4 billion. Cyberonics will hold a 54 percent stake in the new company and Sorin the rest. Cyberonics shareholders will receive one share of the new company for every share held, while Sorin...

  • Feb 17- Medical device maker Boston Scientific Corp on Tuesday said it has agreed to pay $600 million to Johnson& Johnson to settle a long-running lawsuit over Boston Scientific's 2005 acquisition of rival Guidant. J&J had sought more than $7 billion in damages after it lost a bidding war to Boston Scientific following an initial deal to buy Guidant for $21.5...

  • Feb 17- Medical device maker Boston Scientific Corp on Tuesday said it has agreed to pay $600 million to Johnson& Johnson to settle a long-running breach of merger lawsuit over Boston Scientific's 2005 acquisition of rival Guidant. J&J, which agreed to permanently dismiss its action without acknowledgment of liability by Guidant, had sought more than $7...

  • Feb 17- Medical device maker Medtronic Plc reported a better-than-expected quarterly profit, helped mainly by increased sales in its cardiac and vascular business, its largest. With sales of $2.22 billion in the third quarter ended Jan. 23, the business accounted for a little over half of overall sales. The company, which completed its acquisition of Ireland-...